GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BlackRock Health Sciences Trust II (NYSE:BMEZ) » Definitions » Debt-to-Asset
中文

BlackRock Health Sciences Trust II (BlackRock Health Sciences Trust II) Debt-to-Asset

: 0.00 (As of Dec. 2023)
View and export this data going back to 1990. Start your Free Trial

BlackRock Health Sciences Trust II's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. BlackRock Health Sciences Trust II's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.29 Mil. BlackRock Health Sciences Trust II's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $1,954.07 Mil. BlackRock Health Sciences Trust II's debt to asset for the quarter that ended in Dec. 2023 was 0.00.

BlackRock Health Sciences Trust II Debt-to-Asset Historical Data

The historical data trend for BlackRock Health Sciences Trust II's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BlackRock Health Sciences Trust II Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
- - - -

BlackRock Health Sciences Trust II Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Asset Get a 7-Day Free Trial - - - - -
Competitive Comparison

For the Asset Management subindustry, BlackRock Health Sciences Trust II's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BlackRock Health Sciences Trust II Debt-to-Asset Distribution

For the Asset Management industry and Financial Services sector, BlackRock Health Sciences Trust II's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where BlackRock Health Sciences Trust II's Debt-to-Asset falls into.


BlackRock Health Sciences Trust II Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

BlackRock Health Sciences Trust II's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0 + 0.292) / 1954.072
=0.00

BlackRock Health Sciences Trust II's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0 + 0.292) / 1954.072
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BlackRock Health Sciences Trust II  (NYSE:BMEZ) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

BlackRock Health Sciences Trust II Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of BlackRock Health Sciences Trust II's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

BlackRock Health Sciences Trust II (BlackRock Health Sciences Trust II) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BlackRock Health Sciences Trust II (NYSE:BMEZ) » Definitions » Debt-to-Asset
Comparable Companies
GAB EVT BIGZ BTT NAC ECAT BDJ VRTS RVT ETV BLK BX OSTO:INVE A KKR TSX:BN APO BK AMP XSWX:PGHN LSE:III
Traded in Other Exchanges
N/A
Address
100 Bellevue Parkway, Wilmington, DE, USA, 19809
Website
https://www.blackrock.com
BlackRock Health Sciences Trust II is a closed-end management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.
Executives
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Arthur Philip Steinmetz director 50 HUDSON YARDS, NEW YORK NY 10001
Aaron David Wasserman officer: Chief Compliance Officer 50 HUDSON YARDS, NEW YORK NY 10001
Christopher Accettella other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Lorenzo Flores director 2100 LOGIC DRIVE, SAN JOSE CA 95124
James Phillip Holloman director P.O. BOX 625737, 6800 CINTAS BOULEVARD, CINCINNATI OH 45262
Stayce D. Harris director 1999 S. BASCOM AVE., SUITE 700, CAMPBELL CA 95008
Trent Walker officer: Chief Financial Officer C/O PIMCO, 650 NEWPORT CENTER DRIVE, NEWPORT BEACH CA 92660
Xiang Liu other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Jeffrey Gene Lee other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Frank Fabozzi director 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Robert Glenn Hubbard director 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Robert W Fairbairn director 55 EAST 52ND STREET, NEW YORK NY 10055
Cynthia Egan director 7117 BELLONA AVENUE, BALTIMORE MD 21212